by Flor Muñoz, MD, MSc, FAAP; Mark H. Sawyer, MD, FAAP, FIDSA; and Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
Data suggest that immune protection from the inactivated influenza vaccine (IIV) may wane over a single season. Our featured experts discuss these ......READ MORE
by Flor Muñoz, MD, MSc, FAAP; Mark H. Sawyer, MD, FAAP, FIDSA; and Tina Q. Tan, MD, FAAP, FIDSA, FPIDS
Vaccine hesitancy is a growing problem in both the general public and in the pediatric population. Our featured experts share their thoughts on how......READ MORE
Patients with asthma are at an increased risk for developing complications from influenza, which may include pneumonia and secondary bacterial infe......READ MORE
Every patient encounter can be viewed as an opportunity to update and complete an adolescent’s immunizations, and the influenza vaccine is no excep......READ MORE
Testing for respiratory pathogens in the context of influenza-like illness remains an important tool for clinicians. Influenza testing is not routi......READ MORE
To maximize their efficacy, the 3 or 4 constituents of each season’s influenza vaccines are selected based on surveillance data and forecasts of wh......READ MORE
